The medical biology laboratory market - Spain

Medical biology laboratories play a central role in modern healthcare systems. They analyze biological samples (blood, urine, tissue, etc.) to diagnose, prevent and monitor disease. These structures are essential to clinical decision-making, and their efficiency determines the quality of care provided to the population. on a European scale, the most advanced countries in the healthcare sector - such as France andGermany - devote a significant proportion of their GDP to healthcare expenditure, 11.3% and 11.25% respectively in February 2020. France, with around 130 billion euros of expenditure, leads the way, while Spain is in 9ᵉ position within the European Union. This reflects the growing importance of medical biology in public health policies. In Spain, the laboratory market is growing steadily, despite a slowdown after the COVID-19 pandemic, which had strongly boosted activity in the sector. Nevertheless, the need for screening, monitoring and diagnosis remains high, not least because of the ageing population and changing medical practices. A major new trend is shaping this sector: the growing integration of data, Big Data and artificial intelligence. These technologies can be used, for example, to establish reference values,improve quality,support clinical decision-making and monitor public health. Innovative initiatives are emerging, such asautomated urinary sediment analysis, disease prediction andbiological data interpretation. In clinical microbiology, AI is already being used to detect and identify pathogenic micro-organisms, as well as to spot antibiotic resistance.